Member Info for Knottee

This article shows how well TRX is doing from the merger will CellRight. https://uk.finance.yahoo.com/news/hardman-co-research-tissue-regenix-061501335.html Hardman & Co Research14-Sep-2018 / 07:15 GMT/BST The share price is another story but until we get to 2020 and breakeven this is just something we will have to live with. Personally I think it's a good buying opportunity

That's a shame the 300p support didn't hold. This is now looking like quite a bargain. Agree with earlier posts that this is a strong company with a fantastic product and with a well developed plan of growth that only now is beginning to be rolled out. I will be eagerly waiting for trading updates from the NY store once it opens ahead of Xmas. A

Phil Cauldwell CEO of Ceres interviewed by Proactive Investors in relation to the Weichai Power and overall future outlook. See link https://youtu.be/RHOw-DC2byo

I was under the impression that the year end results for 2016 were due in May. Is there a problem. TRX should give guidance or explain the delay.

Yesterday Woodford Investment Management bought 2,450,000 shares taking their holding from 18% to 19%. A vote of confidence and good sign that Woodford believes TRX has a bright future.

Trx is consistent in that it's products all excell in what they do. Up to now the share price has needed a drip feed of 'news' and updates to keep it supported. If too long a gap between news items the share price sinks. Whilst this will still apply, I think in 2017 it will get additional support from actual revenue data and hopefully in the not too distant future revenue will do all the talking.

The future looks bright but it won't hit the big time until 2018....... I suspect that at that point the opportunity of being able to buy shares in TRX for 18p will be long gone!! Fill your boots while you can. https://www.fool.co.uk/investing/2016/05/23/are-glaxosmithkline-plc-tissue-regenix-group-plc-and-optibiotix-health-plc-must-have-health-stocks/

Woodford has increased stake from 15.96% to 17% on 9 mArch. I remember on the 9 March that a sum of over 3.5m shares went through recorded as a sale. This was clearly not a sale. i have had the same experience when i have bought TRX and my purchase is recorded as a sale. Weird. Clearly Woodford is liking the progress at TRX and still believes in TRX as a long term success story. The spreads of late between buys and sells seem to be higher than normal .....maybe there are limited shares now available in free float.

http://www.***************************/tissue-regenix-group-plc-from-development-into-the-commercial-world/412690200 The best analysis I've seen to date. Contents are extremely encouraging.

£100k over 12 months and now £252k over 6 months!! This acorn has truely sprouted. what is even more amazing is that this performance is just on the back of one product....but TRX is not a one trick pony and the uses of its core technology are huge with plenty new products in the pipeline. If Woodford and Invesco don't sell out we will see TRX turn into a FTSE 100 .....perhaps replacing Smith & Nephew (will hip replacements be needed in the future??).

TRX is still overlooked for now....but the author of this article clearly understands the company's potential. http://www.fool.co.uk/investing/2015/09/07/why-astrazeneca-plc-dechra-pharmaceuticals-plc-and-tissue-regenix-group-plc-are-a-perfect-healthcare-combination/

I feel that these are largely buys.... not sells and are just showing incorrectly.... the prices attained look to me to be inconsistent with a sell. My own trade of 53,018 shares on 03/07/15 at 15.46pm is in fact a buy (but it shows as a sell) ....that I know for sure.

There is a meeting and conference call for analysts at 9.00 a.m. today. management will be quizzed and the results discussed. The prospects for BREE over the next 3 years look very good. This is a gem of a company and well run....glad they are holding off on the divi for now. I would expect alot of upgrades to the share price from analysts post this meeting.

Very insightful and yes i think it is very plausible. i note all sells today too.... though the buys stand out at about 11.8p From what you were saying am i right in saying that you feel this presents an opportunity on the upside (once the sell order has been worked off)?

What is showing as a sell is actually a buy. The trade at 8.01 a.m for 10,162 shares was mine and this was most definately a buy and those 10,162 shares are now in my ISA, have been waiting until today to do this as AIM stocks couldn't be added to an ISA until now. Looking forward to seeing the SP rise as the contract win news comes in.

Riverboy, I agree that is poor form on the part of STOB. Like you I am a small sharholder but that shouldn't mean our questions have no significance. I have also contacted their Investor relations and copied in the head of the airline division.....but no response. Will keep you posted.

The Interim management statement certainly gives confidence in the year ahead. I'd say in challenging times STOB is doing well......the big omission from my point of view was no update on the planning permission for CArlisle Airport. Any one know of news on this? If they got the green light and did as good a job as they have at Southend it would be a goldmine as no other airport serves that part of the UK 'gateway to the Lakes' etc